Browsing: Novo

By Andrew Silver SHANGHAI (Reuters) – Novo Nordisk (NYSE:)’s hugely popular weight-loss drug Wegovy has been approved in China, it…

By Andrew Silver SHANGHAI (Reuters) – Novo Nordisk (NYSE:) is facing the prospect of intensifying competition in the promising Chinese…

By Maggie Fick LONDON (Reuters) – Novo Nordisk (NYSE:)’s Wegovy obesity drug reduced adverse kidney-related events by 22% in overweight…

The blockbuster diabetes drug Ozempic could be manufactured for less than $5 a month, even as Novo Nordisk charges close…

BAGSVÆRD, Denmark – Novo Nordisk (NYSE:), a global healthcare company, has announced its agreement to purchase Cardior Pharmaceuticals for up…

In a series of transactions this week, Novo Holdings A/S, a significant shareholder in Spruce Biosciences, Inc. (NASDAQ:SPRB), has sold…